Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Jan
19
2022
New York Enacts Landmark Legislation Regulating PBMs Proskauer Rose LLP
Jan
19
2022
FDA Publishes Paper on Asbestos Testing in Cosmetics Keller and Heckman LLP
Jan
19
2022
Securities Litigation Update: Federal Courts Allow Section 10(b) Claims Based on Non-Fraudulent “Channel Stuffing” and Hyped COVID-19 Vaccine Candidate Cadwalader, Wickersham & Taft LLP
Jan
19
2022
Coffee Burn Injury Lawsuits Buckfire Law
Jan
18
2022
“Show More of You”: Amgen v. Sandoz, Battling it Out on Amgen’s Otezla® Drug Finnegan
Jan
18
2022
US Federal Labor Viewpoints – Week of January 10, 2022 Squire Patton Boggs (US) LLP
Jan
18
2022
COVID-19 Vaccination Sweepstakes: Best Practices for Employee Incentives K&L Gates
Jan
18
2022
New Guidelines for Good Manufacturing Practices Concerning Medical Devices in Mexico OLIVARES
Jan
18
2022
Federal Marijuana Reform: You Can’t Always Get What You Want? Bradley Arant Boult Cummings LLP
Jan
18
2022
Co-Owner of Clinical Trial Company Pleads Guilty to Obstruction of Justice in Connection with Falsification of Clinical Trial Data Mintz
Jan
18
2022
Supreme Court Halts Implementation of OSHA Vaccine-or-Test Rule (US) Squire Patton Boggs (US) LLP
Jan
18
2022
OSHA’s “Vax-or-Test” ETS: Where Do We Go From Here? (US) Squire Patton Boggs (US) LLP
Jan
18
2022
Not Positive: Last Week’s Lab Fraud Schemes Tycko & Zavareei LLP
Jan
18
2022
Tennessee Lawmakers to Consider Multiple Cannabis Proposals Bradley Arant Boult Cummings LLP
Jan
18
2022
Egg Regulatory Program Standards Announced Keller and Heckman LLP
Jan
15
2022
After the Supreme Court Decision, What Comes Next for OSHA and COVID-19 Beveridge & Diamond PC
Jan
15
2022
Minneapolis and St. Paul to Require Proof of Vaccination or Negative Test for Certain Businesses Jackson Lewis P.C.
Jan
15
2022
Building on the Success of Medicare-Medicaid Plans, CMS Proposes Modifications for D-SNPs Mintz
Jan
15
2022
Greenberg Traurig January 2022 Competition Currents: China and Japan Greenberg Traurig, LLP
Jan
14
2022
New York City Passes the Sweet Truth Act Keller and Heckman LLP
Jan
14
2022
Italian Ministers Announce Timetable for Investment in Digital Health Squire Patton Boggs (US) LLP
Jan
14
2022
EPA Accepting Comments on Candidates to Be Ad Hoc Reviewers for Draft TSCA Systematic Review Protocol Bergeson & Campbell, P.C.
Jan
14
2022
Amniotic Fluid Injections Are at the Center of the Federal Government’s New Enforcement Effort Oberheiden P.C.
Jan
14
2022
SCOTUS Narrowly Allows CMS Vaccine Mandate to Survive; Preemption Battles to Ensue Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jan
13
2022
Mississippi Senate Overwhelmingly Approves Medical Cannabis Act, Sending Act to House Bradley Arant Boult Cummings LLP
Jan
13
2022
CMS “Splits the Baby” on Aduhelm—Medicare Coverage but Only with Evidence Development for Now Epstein Becker & Green, P.C.
Jan
13
2022
FDA Revokes Standard for French Dressing Keller and Heckman LLP
Jan
13
2022
Day Three Notes for the 40th Annual J.P. Morgan Healthcare Conference, 2022 Sheppard, Mullin, Richter & Hampton LLP
Jan
13
2022
McDermott 2022 Health Policy Outlook McDermott Will & Emery
Jan
13
2022
Going, Going, Gone? Regulatory Nexus in TSCA Risk Evaluations of Existing Chemicals Keller and Heckman LLP
Jan
13
2022
US Supreme Court Halts Federal Vaccination Mandate for Employers, but Permits CMS Rule to Take Effect Varnum LLP
Jan
12
2022
Planting the Seeds: The Present State and Potential Prospects of Medical Cannabis in Tennessee Bradley Arant Boult Cummings LLP
Jan
12
2022
CMS Proposes Rule to Lower Part D Drug Costs for Beneficiaries K&L Gates
Jan
12
2022
FDA Releases Guidances on Transition Plan for Devices Distributed Under Emergency Use Authorization (EUA) or Enforcement Policies During COVID-19 Sheppard, Mullin, Richter & Hampton LLP
Jan
12
2022
Taking Stock of the Alabama Medical Cannabis Sweepstakes: Still Time to Enter Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins